A day after the New Orleans Saints running back was suspended for violating the NFL policy on performance-enhancing substances, Ingram’s representative, David W. Jones, released a statement stating he will challenge the ruling through the arbitration process.
“At the end of the 2017 season, as a result of a NFL mandated random drug test, Mark Ingram tested positive for a substance that was not a performance enhancing substance, nor an illegal substance, but a substance in fact permissible with the proper use exemption with the NFL,” Jones said in a statement obtained by NFL Network Insider Ian Rapoport. “He has vigorously challenged the test results through the arbitration process. The arbitrator’s Opinion is due on or before Wednesday, May 16. Upon having the opportunity to review the arbitrator’s opinion, we will explore what further options are needed.”
Barring an overturned judgment, The Saints running back is going to miss games against the Buccaneers, Browns, Falcons and Giants. Ingram is allowed to participate in all offseason and preseason practices and games
Mark Ingram led the Saints in rushing last season with 1,124 yards on 230 carries with 12 TDs. With Offensive Rookie of the Year Alvin Kamara poised to take on a larger role in the offense, Ingram isn’t willing to concede four games as he enters the final year of his deal.
Not great timing for Ingram, especially in a contract year. From a fantasy perspective, Kamara’s stock just went up a bit more. I can see him going first round in fantasy drafts. He might be the #1 overall pick without Ingram in the picture.
